City

Hong Kong (1)

Matsumoto (1)

Condition

Diabetic Macula Edema (3)

Overall Status

Completed (1)

Unknown status (1)

Withdrawn (1)

Sign in for free

Phase

phase 4 (2)

phase 3 (1)

Sponsor

Novartis Pharmaceuticals (1)

Shinshu University (1)

The University of Hong Kong (1)

Intervention

ranibizumab (2)

aflibercept (1)

bevacizumab (1)

brolucizumab (1)

end-point-management grid laser (1)

photocoagulation (1)

Study Documents

Intervention Type

drug (3)

procedure (2)

Funder Type

Other (2)

Industry (1)

Study Type

Interventional (3)

diabetic macula edema

Showing 1 - 3 of 3

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Diabetic Macula Edema Trial (Brolucizumab, Aflibercept)

Withdrawn

Diabetic Macula Edema

(no location specified)

Mar 2, 2021

Diabetic Macula Edema Trial in Matsumoto (Photocoagulation, Ranibizumab)

Completed

Diabetic Macula Edema

Photocoagulation
Ranibizumab

Matsumoto, Nagano, Japan

Department ou Ophthalmology Shinshu University School of Medicin

Sep 5, 2018

Diabetic Macula Edema Trial in Hong Kong (End-Point-Management grid laser, ranibizumab, Bevacizumab)

Unknown status

Diabetic Macula Edema

End-Point-Management grid laser
+2 more

Hong Kong, China

The University of Hong Kong

Apr 17, 2016